ATAI Life Sciences Q1 EPS $(0.17) Beats $(0.18) Estimate, Cash $18.87M
Portfolio Pulse from Benzinga Newsdesk
ATAI Life Sciences reported a Q1 EPS of $(0.17), beating the analyst consensus estimate of $(0.18) and showing a 19.05% improvement over the same period last year. The company has $18.87M in cash.
May 15, 2024 | 11:57 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
ATAI Life Sciences reported a Q1 EPS of $(0.17), beating the analyst consensus estimate of $(0.18) and showing a 19.05% improvement over the same period last year. The company has $18.87M in cash.
Beating EPS estimates and showing year-over-year improvement in losses is a positive indicator for ATAI's stock price in the short term. The company's cash position also provides a cushion for future operations.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100